Chek.Jk
CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
CHEK.JK maintains a strong liquidity position with a current ratio of 4.41, indicating the company can easily cover its short-term liabilities with its current assets. The company holds significant cash and equivalents of 50,019,482,560, which provides a buffer against short-term obligations. However, the operating cash flow is negative at -43,150,544,260, suggesting that the company's core operations are not generating positive cash flow. The free cash flow is also negative at -4,187,527,380, indicating that the company is not generating enough cash to fund its operations and capital expenditures.
In terms of profitability, CHEK.JK has a return on equity (ROE) of 6.64% and a return on assets (ROA) of 5.4%, which are both below the industry median for medical equipment and supplies distribution. The company's net income of 14,023,055,380 is supported by a gross profit of 77,139,953,520, but the operating income of 23,153,085,590 is relatively modest compared to its revenue of 201,306,181,380. The company's debt-to-equity ratio of 0.09 is low, indicating a conservative capital structure with minimal reliance on debt financing.
CHEK.JK's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification in the provided data. The company's exposure to a single industry increases its vulnerability to sector-specific risks, such as regulatory changes or shifts in healthcare demand. The lack of geographic diversification data suggests that the company may be heavily reliant on a specific region, which could pose a concentration risk if that region experiences economic or political instability.
The company's growth trajectory is not clearly defined in the provided data, as there are no specific revenue growth projections for the current or next fiscal year. However, the negative operating and free cash flows indicate that the company may be investing heavily in its operations or facing operational challenges that could impact its growth potential. The capital expenditure of -28,438,205,630 suggests that the company is making significant investments in its infrastructure or equipment, which could be a sign of expansion or modernization efforts.
The risk assessment for CHEK.JK indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves contribute to its strong liquidity position. The risk of dilution is also low, as the number of shares outstanding for both basic and diluted shares is the same, indicating no potential for share dilution from stock options or convertible securities. The company's conservative capital structure and strong liquidity position reduce the likelihood of financial distress in the near term.
Recent events and filings for CHEK.JK do not show any significant developments that would impact its financial position or risk profile. The absence of filing-based liquidity or dilution flags suggests that the company is maintaining a stable financial position without the need for urgent capital raising or restructuring. The company's financial statements and disclosures provide a clear picture of its operations and financial health, with no red flags indicating potential issues.
- CHEK.JK has a strong liquidity position with a current ratio of 4.41 and significant cash reserves.
- The company's profitability metrics, including ROE and ROA, are below the industry median.
- CHEK.JK's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification.
- The company is making significant capital expenditures, which could indicate expansion or modernization efforts.
- The risk of liquidity and dilution is low, with no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- CHEK.JK Market data — financials · 2026-05-27